Company / Total Assets
Zoetis Total Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$15.5B
FY2025
5-year range
$13.9B / $15.5B
FY2021-FY2025
Trend
+8.6%
vs FY2024
Sector context
#17 of 214
Health Care
What the data says
Among 214 Health Care companies, Zoetis is in the top 8% for total assets. Total Assets returned to growth in FY2025 after 2 years of decline, reaching $15.5B.
Based on SEC 10-K filings.
$15.5B in FY2025 with a 5-year CAGR of +2.6%. Top quartile in the Health Care sector.
Improved from $14.3B to $15.5B over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- +1.2%
- 5-Year CAGR
- +2.6%
- 10-Year CAGR
- -
Sector benchmark
Top 8% in Health CareTop 8% of 214This company $15.5B Sector average $7.5B
▼
+107.1% above sector average
Key checks
Key Insights
- 5-year CAGR of +2.6%, indicating consistent growth.
- In FY2025, total assets increased 8.6% year-over-year.
- Ranks #17 out of 214 companies in the Health Care sector.
- Lowest total assets in the period was in FY2016.
Company context
Key Data Points
- Strong profit margin: 28.2%
- Strong return on equity: 49.1%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $15.5B | +8.6% |
| FY2024 | $14.2B | -0.3% |
| FY2023 | $14.3B | -4.3% |
| FY2022 | $14.9B | +7.4% |
| FY2021 | $13.9B | +2.1% |
| FY2020 | $13.6B | +17.9% |
| FY2019 | $11.5B | +7.1% |
| FY2018 | $10.8B | +25.5% |
| FY2017 | $8.6B | +12.2% |
| FY2016 | $7.6B | -3.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026